Lilly to Participate in Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference

INDIANAPOLIS, Nov. 17, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference on Thursday, November 30, 2017. Dan Skovronsky, M.D., Ph.D., senior vice president of Clinical and Product Development at Lilly, will participate in a fireside chat at 4:15 p.m., Eastern time.

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at http://investor.lilly.com/events.cfm. A replay of the presentation will be available on this same website for approximately 90 days.

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels.  F-LLY   

Refer to:
Lauren Zierke; lauren_zierke@lilly.com; (317) 277-6524 (Media)   
Phil Johnson; johnson_philip_l@lilly.com; (317) 655-6874 (Investors)

View original content with multimedia:http://www.prnewswire.com/news-releases/lilly-to-participate-in-evercore-isi-2017-biopharma-catalystdeep-dive-conference-300558966.html

SOURCE Eli Lilly and Company